Introduction
Autism spectrum disorders (ASDs) are neurodevelopmental diseases characterized by restricted interests, repetitive behaviors, and deficient language and social skills [1] . Although there are no concrete biological markers for the disorder, immune anomalies are frequently described among individuals with ASDs and their family members [2, 3] . Historically, studies chronicling an immunological component in ASDs have been inconsistent and controversial; this is due in part to small sample sizes, inappropriate controls, and no consideration for phenotypic heterogeneity of ASDs. Recent studies have readily addressed these concerns, and the immunological connection for ASDs is becoming widely accepted. Figure 1 illustrates the potential interactions between the immune and neural systems in ASDs. The following presents the most recent findings linking immunity to autism.
Altered immunity in individuals with autism spectrum disorders
Immunological anomalies involving cytokines, immunoglobulins, inflammation, and cellular activation have been noted in individuals with autism.
Altered cytokine profiles
Skewed cytokine profiles have been repeatedly linked to ASDs [4] [5] [6] [7] [8] . Cytokines are secreted proteins that control the intensity, duration, and character of an immune response. Cytokines also interact with neural systems and are involved in neural development and maintenance [9] .
Transforming growth factor beta (TGF-b) has been linked to ASDs in multiple studies [10] [11] [12] . TGF-b is involved in diverse aspects of development, cell migration, apoptosis, and regulation in both the immune system and central nervous system (CNS) [13, 14] . Independent studies have described decreased levels of TGF-b in blood samples from individuals with ASDs. Okada et al. [10] reported their findings among a group of adults with ASDs compared with age-matched controls. Similar data were reported by Ashwood et al. [11] in a large, thoroughly characterized group of children and found that lower TGF-b correlated with more severe behavioral scores in ASD children. In contrast to the observation of lower TGF-b in peripheral blood, TGFb levels in postmortem brain and cerebrospinal fluid samples were higher in persons with ASDs than those in controls [12] . Although the relationship between CNS and peripheral TGF-b is unclear, these studies collectively suggest that TGF-b dysregulation may have a lifelong role in ASDs.
Another cytokine recently linked to ASDs is macrophage inhibitory factor (MIF) [15] . MIF is a pro-inflammatory immune regulator that is constitutively expressed in brain tissues [16] and has important influences on neural and endocrine systems [17] . Genotyping studies on more than 1000 families uncovered two polymorphisms in the promoter region of MIF that is associated with autism. Additionally, plasma levels of MIF were higher in individuals with autism than in typically developing controls [15] . Finally, individuals with autism with the highest levels of plasma MIF were found to have the most severe behavioral symptoms [15] .
Variations in plasma levels of the cytokine/hormone leptin have been noted among individuals with ASDs [18] . Leptin is produced primarily by adipocytes, although recent evidence shows that it is also produced by lymphocytes [19] . Leptin shares functional similarities with inflammatory cytokines such as interleukin (IL)-6 and IL-12 [20] and is capable of crossing the blood-brain barrier [21] . Ashwood et al. [18] recently demonstrated that plasma leptin levels were elevated in a large well characterized population of children with ASDs compare with those in typically developing controls. This was especially dramatic among children with early-onset autism as opposed to those with clinical regression (i.e. normal development followed by loss of skills). Vargas et al. [12] also noted increased levels of leptin in postmortem brain samples from persons with autism. During postnatal life, an intact blood-brain barrier limits the entry of immune species into the brain. Lymphocytes, macrophages, various cytokines, and antibodies are generally maintained in the periphery. However, the blood-brain barrier is permeable during fetal development and can be compromised by infections and environmental exposures throughout life. The absence of a complete barrier allows immune components access to the brain. Individuals with autism show increased pro-inflammatory cytokines in the brain, as well as activation of resident immune cells known as microglia. Additionally, antibodies that target brain tissues have been described in both children with autism and their mothers. These immunological phenomena may interfere with normal brain development and function, potentially contributing to the development and/or symptoms of autism spectrum disorders (ASDs).
Collectively, the most exciting revelation in the above studies is the relationship between particular cytokine levels and behavioral variations within the autism spectrum. With continued research, cytokines may become an easily measured biomarker for phenotypic variations within ASDs. It is unclear whether altered cytokine levels are harmful or beneficial or whether immune modulation therapy would benefit certain individuals with ASDs.
Immunoglobulin levels
Immunoglobulins (Ig) are proteins produced by B cells that specifically target entities for destruction and removal. There are several classes of Ig, each with a specific role in immunological processes. Recently, decreased levels of total plasma IgG and IgM were described in a large group of individuals with autism compared with age-matched individuals without autism [22 ] . The reduced levels also correlated with behavior, such that individuals with autism with the most severe behavioral symptom scores had the lowest IgG and IgM levels [22 ] . Further characterization of IgG subclasses demonstrated that young children with autism have significantly higher levels of IgG 4 compared with agematched typically developing children [23] . Although the relationship between reduced total Ig and behavior is unclear, it is possible that a defect in a shared signaling pathway leads to both altered neurodevelopment and immune function. Studies are currently underway to examine this hypothesis.
Altered cellular immunity

Alterations in various immune cells including natural killer (NK) cells and macrophages have been noted in individuals with autism.
Functional differences in natural killer cell activity Natural killer cells are unique members of the immune system with roles in the viral response, pregnancy maintenance, tumor cytotoxicity, and autoimmunity [24] . Examination of peripheral blood cells in individuals with ASDs revealed differences in the expression of several genes related to NK cell activity [25] . Further analysis of NK cells confirmed that the genetic alterations showed functional significance [26, 27] . Resting cells from children with ASDs had increased expression of several NK cell receptors and effector molecules. Interestingly, upon stimulation, NK cells from individuals with ASDs showed diminished cytotoxic activity compared with controls [27] . Similar findings were reported by Vojdani et al. [26] , whose analysis of blood from over 1000 individuals showed reduced NK cell activity in ASDs compared with persons with ASDs. The nature of the link between NK cells and ASDs is not clear, although NK cells are known to produce cytokines and cytotoxic substances that could impact the CNS [28] [29] [30] .
Monocyte response to Toll-like receptor stimulation Monocytes are innate immune cells found in the peripheral blood that identify pathogens and direct the subsequent immune response. Monocytes express Tolllike receptors (TLRs), which recognize molecular patterns associated with viruses and bacteria. A recent study examined monocyte cytokine responses to TLR stimulation in a well characterized group of individuals with ASDs and matched individuals without ASDs. Dramatic differences were observed between the groups following stimulation of various TLRs. TLR-2 and TLR-4 stimulation of monocytes caused a marked production of proinflammatory cytokines in individuals with ASDs that was not observed in the comparison group. Conversely, TLR-9 stimulation showed a decreased production of pro-inflammatory cytokines in the ASDs compared with the group without ASDs. This suggests that monocytes from children with ASDs respond differently to innate immune stimulation compared with controls. Given the integral role of monocytes in the direction of an immune response, altered response to TLR stimulation can have wide-ranging impacts [31 ] .
Neuroinflammation
Some individuals with ASDs demonstrate active inflammation in the CNS (reviewed in [32] ). Postmortem brain and spinal cord samples from 11 individuals with ASDs showed increased activation of astroglia and microglia and increased levels of cytokines monocyte chemotactic protein-1 (MCP-1) and TGF-b compared with control specimens [12] . A more recent study of postmortem brain tissues by Li et al. [33 ] further demonstrated CNS inflammation in persons with ASDs. Cytokine levels were measured in homogenized brain samples from individuals with ASDs and compared to levels in specimens from age-matched and sex-matched individuals without ASDs. Specimens from persons with ASDs demonstrated a significant increase in pro-inflammatory and Th1 cytokines. Postmortem studies are often limited by the availability of quality specimens from appropriately characterized individuals. However, these studies give valuable insight into the immune status of the CNS in some persons with ASDs. It is unclear whether CNS immune activation contributes to the pathology of autism or whether it is an epiphenomenon.
Altered sensitivity to environmental toxicants: polybrominated diphenyl ethers, immunity, and autism
A complex interplay between immunological and environmental factors may have a role in autism. Polybrominated diphenyl ethers (PBDEs) are environmental toxicants that impact neurodevelopment and immunity [34] [35] [36] [37] . A 2009 study by Ashwood et al. [38 ] explored the interaction between PBDEs and cellular immunity in
The immune system in the biology of autism Goines and Van de Water 113 children with ASDs. Peripheral blood mononuclear cells from ASDs and typically developing children were pretreated with a PBDE, stimulated with the bacterial derivative lipopolysaccharide (LPS), and compared with non-PBDE-treated cell cultures. PBDE treatment of control cultures led to reduced production of inflammatory cytokines and chemokines. This suggests that PBDEs suppress immune responses in neurotypical populations. In contrast, PBDE-treated cultures from persons with ASDs showed dramatically increased production of pro-inflammatory cytokines and chemokines. These results suggest that individuals with ASDs have different immune sensitivity to the environmental toxicant than neurotypical children [38 ] . This may be indicative of differential genetic susceptibility to PBDEs and/or a breakdown of proper immune regulation in ASDs.
Allergy and autism spectrum disorder
Some have postulated that allergic disease may be associated with ASDs. However, many early studies linking allergy to ASDs lacked appropriate control groups [39, 40] . Recent properly controlled research suggests no difference in allergic phenomena between persons with ASDs and neurotypical individuals. In a study of allergic sensitization, individuals with ASDs showed no difference in the frequency of allergic disorders, the number of positive skin prick tests, or in serum IgE levels (which are high in allergic individuals) [41] . An independent study also showed no difference in total plasma IgE between individuals with ASDs and a group without ASDs matched for age and geographic location [22 ] .
Autoimmunity in autism spectrum disorder
Autoimmunity occurs when the immune system mistakenly targets the body's own tissues. Various autoimmune phenomena have been described for decades among individuals with autism [3].
Antibodies directed toward neural antigen(s) in individuals with autism spectrum disorder
Many studies have described circulating antibodies directed toward brain proteins in persons with ASDs [3, 42, 43] . A recent study characterized the targets of these antibrain antibodies using immunohistochemical staining of cerebellum sections from rhesus macaques [44] . Individuals with ASDs showed a higher rate of plasma IgG directed toward golgi cells compared with age-matched persons without ASDs [44] . The pathologic significance of these autoantibodies remains unclear, and they may be an epiphenomenon.
Although antibrain antibodies are found significantly more often in persons with ASDs, they are also found occasionally in neurotypical persons and those without ASDs who are developmentally delayed [43, 44] . The presence of these autoantibodies in other populations suggests that they may be a susceptibility factor that requires another exposure, such as a xenobiotic, to abrogate the blood-brain barrier and facilitate access of the autoantibodies to their target antigens. Further studies are needed to resolve this important issue.
Antinuclear antibodies in children with autism spectrum disorder
A recent study examined the occurrence of antibodies directed toward nuclear proteins in a large group of children with autism and age-matched children with typical development [45] . Antinuclear antibodies are observed in autoimmune diseases like systemic lupus erythematosus (SLE). Children with autism had a significantly higher frequency of antinuclear antibodies (20%) than the neurotypical children (2.5%). As discussed below, individuals with SLE often demonstrate neurological abnormalities, suggesting a link between autoimmunity and behavior [46] .
Behavior and autoimmunity
Certain autoimmune disorders impact behavior. This has been demonstrated among individuals with SLE accompanied by neuropsychiatric symptoms [47] . Serum antinuclear antibodies isolated from neuropsychiatric SLE patients cross-react with the N-methyl-D-aspartate (NMDA) receptor for the neurotransmitter glutamate [47, 48] . Further, exposure of mice to serum from patients with SLE led to cognitive impairments and neuronal death in the hippocampus [49] .
Autoantibodies specific to nervous system components have been reported in psychiatric disorders besides ASDs, including schizophrenia, obsessive-compulsive disorder, pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PAN-DAS), and Gilles de la Tourette's syndrome [48, [50] [51] [52] [53] [54] [55] . Antibodies directed toward the brain might interfere with development and function or cause immunemediated destruction.
Immune findings in families of individuals with autism spectrum disorder
Family members of individuals with autism also have various immune abnormalities. Examination of familial immunity in autism provides important insight into the disorder.
Siblings of individuals with autism
Historically, unaffected siblings of children with ASDs have served as healthy controls in various studies. However, unaffected siblings are known to exhibit a higher prevalence of traits that distinguish them from neurotypical populations without qualifying them for an autism diagnosis. For example, neuroimaging studies demonstrated differences in brain function between unaffected siblings and neurotypical populations [56, 57] . Additionally, immune parameters differ between siblings of children with autism and typically developing children [58 ] . A small study of children with autism, their unaffected siblings, and healthy age-matched and sex-matched children without ASDs demonstrated that lymphocyte populations in unaffected siblings were more similar to those of children with autism than to typically developing children [58 ] . Therefore, unaffected siblings should not be used as healthy neurotypical controls in autism research. Additionally, evaluating immunity in healthy siblings may provide important information regarding the relationship between immune dysfunction and autism.
Epidemiological associations for familial noninfectious diseases
Several immunological diseases occur at an increased rate among primary family members of individuals with autism. There is a higher incidence of type 1 diabetes in fathers and ulcerative colitis in mothers of children with ASDs [59] . Independent studies have also suggested that persons with autism have a greater family history of autoimmune disease compared with controls [45] . In children with autism, 47.5% were shown to have a family member with an autoimmune disease, compared with only 8.8% among healthy controls. This is consistent with previous work examining the occurrence of familial autoimmune disorders in autism [60] .
Antibodies to fetal tissue in mothers of children with autism spectrum disorder Exciting immune-related findings in autism come from research involving mothers of children with autism. Independent studies showed that a subset of mothers of children with autism have circulating antibodies that target the fetal brain [42,61 ,62,63] . Certain patterns of these antibodies are only found in mothers of children with autism and are not found in controls [61 ] . The targets of these antibodies in the fetal brain are the topic of current research.
Maternal antibodies (IgG) are transferred across the placenta to the fetus throughout pregnancy [64] . These antibodies serve a protective role until the child's immune system matures and persist in the child's circulation for 6 months after birth [65] . Maternal antibodies are passed without regard to their specificity, meaning that both protective and autoantibodies have equal access to the developing fetus. Maternal autoantibodies can cause disorder in the neonate, which may be transient (in the case of myasthenia gravis) [66] or permanent, as in the case of SLE [67] .
Unlike mothers of children with autism, children with autism, themselves, do not appear to harbor antibodies specific to the fetal brain [68] . Rather, antibodies found in children with autism appear to react with the fully developed brain [43, 44, 69, 70] .
Animal models: gestational exposure to maternal antibodies and offspring behavior Animal models have demonstrated that maternal antibrain antibodies can impact offspring brain development and behavior. In one study, antibodies that bind the neural NMDA receptor were induced in female mice throughout gestation. The resulting offspring demonstrated histological abnormalities in the brain and had cognitive impairments in adulthood [71 ] . Animal models have similarly demonstrated the pathologic significance of brain-directed IgG from mothers of children with autism. In 2008, IgG purified from mothers of children with autism was injected into pregnant rhesus macaque monkeys. A control group of monkeys received IgG from mothers of neurotypical children and the offspring from each group were observed for behavioral differences. Unique stereotypic behaviors were observed in monkeys exposed prenatally to IgG from mothers of children with ASDs [72 ] . A murine model has also demonstrated the impacts of maternal IgG on offspring behavior [73 ] . Prenatal exposure to antibodies from mothers of children with autism led to neurobehavioral alterations that were not observed in mice prenatally exposed to antibodies from control mothers. Collectively, these studies suggest that brain-directed antibodies in mothers have the potential to impact the child's behavioral outcome.
Conclusion
Decades of research links immunological abnormalities to ASDs. In light of the extensive cross-talk between the immune and neural systems, which includes shared signaling and developmental pathways, this line of research can yield important insights into atypical brain development. The nature of the connection between immunity and autism is the focus of ongoing research. To examine the immunobiology of autism, it is important to use healthy, age-matched, comparison groups that do not have a family history of ASDs and take into account the heterogeneity and subtypes within the ASDs population. Proper exploration of immunological features in autism presents an exciting opportunity to tease apart the biology of the disorder and may lead to therapeutic interventions.
